The INSULIN Act contains key policies for which JDRF has long been advocating. We urge the Senate to finalize the bill and pass it quickly. Learn more in our release: jdrf.org/press-releases…

Thank you Sen. Jeanne Shaheen Sen. Susan Collins for your leadership to fix a broken system. We urge all Senators to support this proposal that will take critical steps to lower #insulin prices. No one should have to pay $300/vial for this lifesaving drug. More: ow.ly/26Pa50JF4pf

A vote is expected shortly on an amendment to keep the $35 per month insulin copay cap for commercial insurance in the budget bill. JDRF urges the U.S. Senate to vote ‘yes’ to expand access to affordable insulin.

It’s a tremendous honor to participate in the #PENPLusinAction event at UNICEF house. #T1D is a global problem & it’s tragic the children die for lack of insulin access and care. I’m so proud of @JDRF partnering with Helmsley Charitable Trust to support this incredibly important initiative

JDRF celebrates today’s decision from the U.S. Food and Drug Administration (FDA) to approve teplizumab (under the brand name Tzield) for use in delaying type 1 diabetes (T1D) in at-risk individuals. This is a huge step on the path towards our vision of a world without T1D. (1/2)

ICYMI: President Biden highlighted insulin affordability during tonight's #StateOfTheUnionAddress

Important questions and answers you should know!​ Screening is quick, free, convenient and important for relatives of people who have T1D. If you have a family member with T1D, sign up for free screening at trialnet.org/participate!

BREAKING: Novo Nordisk announced today that it is lowering the list price of several insulin products by up to 75% effective January 1st 2024. (1/3)

Read our full statement here: ow.ly/LiN650NkGmX (4/4)

As #WomensHistoryMonth comes to a close we want to take the opportunity to celebrate one of the most important women at JDRF, our Chief Mission Strategy Officer, Cynthia Rice. (1/3)

Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is free for eligible individuals to evaluate their personal risk of developing Type 1 Diabetes. Learn more about TrialNet Pathway to Prevention here: trialnet.org/our-research/r…

Organizational Announcement x.com/i/broadcasts/1…

Same mission, New name. Breakthrough T1D (formerly JDRF) is the world leader in T1D research, advocacy, and community support. Our new brand reflects our bold vision for a world without T1D. We are accelerating breakthroughs and building a movement for change. #BreakthroughT1D

Thank you, Alex Stepahin from office of ⁦Rep. Richard Hudson⁩ for meeting with our NC #BreakthroughT1D group! We appreciate Congressman Hudson’s support of the SDP and affordable insulin. #GovDay2024

Thank you, Sarah Izaak of ⁦Congresswoman Valerie Foushee⁩ office for taking the time to meet with #BreakthroughT1D NC advocates! We are grateful for Congresswoman Foushee’s support of the SDP, affordable insulin and equitable access to healthcare. #GovDay2024

Thank you, Bryan McVae in office of ⁦Virginia Foxx⁩ for meeting and discussing priorities with #BreakthroughT1D NC-5 advocates! We are grateful for the Congresswoman’s support of the SDP renewal and affordable insulin. #GovDay2024

Many thanks, Fabiana Corsi Mendez, in the office of ⁦Congresswoman Kathy Manning⁩ for meeting with #BreakthroughT1D (formerly JDRF) NC advocates! We appreciate Congresswoman Manning’s support of affordable insulin initiatives, access to care and the Special Diabetes Program. #GovDay2024

The Breakthrough T1D Advocacy family honors the life of Flash Black – a longstanding Advocacy Team Chair based in Knoxville, TN who passed away earlier this week. Flash was a steadfast leader and #T1D champion since his adult son – Rock – was diagnosed as a child. 1/3

Our funded research to cure, prevent, and treat type 1 diabetes (T1D) and its complications also has the potential to impact other autoimmune diseases. Read more at the link below. bit.ly/4bdaZPT